{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T06:14:51Z","timestamp":1772172891358,"version":"3.50.1"},"update-to":[{"DOI":"10.1371\/journal.pcbi.1009421","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2022,10,18]],"date-time":"2022-10-18T00:00:00Z","timestamp":1666051200000}}],"reference-count":33,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T00:00:00Z","timestamp":1660867200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"abstract":"<jats:p>\n                    Cancer is a complex disease with usually multiple disease mechanisms. Target combination is a better strategy than a single target in developing cancer therapies. However, target combinations are generally more difficult to be predicted.\n                    <jats:italic>C<\/jats:italic>\n                    urrent CRISPR-cas9 technology enables genome-wide screening for potential targets, but only a handful of genes have been screend as target combinations. Thus, an effective computational approach for selecting candidate target combinations is highly desirable. Selected target combinations also need to be translational between cell lines and cancer patients. We have therefore developed\n                    <jats:bold>DSCN (<\/jats:bold>\n                    <jats:underline>\n                      <jats:bold>d<\/jats:bold>\n                    <\/jats:underline>\n                    <jats:bold>ouble-target<\/jats:bold>\n                    <jats:underline>\n                      <jats:bold>s<\/jats:bold>\n                    <\/jats:underline>\n                    <jats:bold>election guided by<\/jats:bold>\n                    <jats:underline>\n                      <jats:bold>C<\/jats:bold>\n                    <\/jats:underline>\n                    <jats:bold>RISPR screening and<\/jats:bold>\n                    <jats:underline>\n                      <jats:bold>n<\/jats:bold>\n                    <\/jats:underline>\n                    <jats:bold>etwork)<\/jats:bold>\n                    , a method that matches expression levels in patients and gene essentialities in cell lines through spectral-clustered protein-protein interaction (PPI) network. In DSCN, a sub-sampling approach is developed to model first-target knockdown and its impact on the PPI network, and it also facilitates the selection of a second target. Our analysis first demonstrated a high correlation of the DSCN sub-sampling-based gene knockdown model and its predicted differential gene expressions using observed gene expression in 22 pancreatic cell lines before and after MAP2K1 and MAP2K2 inhibition (\n                    <jats:italic>R<\/jats:italic>\n                    <jats:sup>2<\/jats:sup>\n                    = 0.75). In DSCN algorithm, various scoring schemes were evaluated. The \u2018diffusion-path\u2019 method showed the most significant statistical power of differentialting known synthetic lethal (SL) versus non-SL gene pairs (\n                    <jats:italic>P<\/jats:italic>\n                    = 0.001) in pancreatic cancer. The superior performance of DSCN over existing network-based algorithms, such as OptiCon and VIPER, in the selection of target combinations is attributable to its ability to calculate combinations for any gene pairs, whereas other approaches focus on the combinations among optimized regulators in the network. DSCN\u2019s computational speed is also at least ten times fast than that of other methods. Finally, in applying DSCN to predict target combinations and drug combinations for individual samples (DSCNi), DSCNi showed high correlation between target combinations predicted and real synergistic combinations (\n                    <jats:italic>P<\/jats:italic>\n                    = 1e-5) in pancreatic cell lines. In summary, DSCN is a highly effective computational method for the selection of target combinations.\n                  <\/jats:p>","DOI":"10.1371\/journal.pcbi.1009421","type":"journal-article","created":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T13:47:25Z","timestamp":1660916845000},"page":"e1009421","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["DSCN: Double-target selection guided by CRISPR screening and network"],"prefix":"10.1371","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3162-461X","authenticated-orcid":true,"given":"Enze","family":"Liu","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0511-9436","authenticated-orcid":true,"given":"Xue","family":"Wu","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1904-1737","authenticated-orcid":true,"given":"Lei","family":"Wang","sequence":"additional","affiliation":[]},{"given":"Yang","family":"Huo","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0346-6044","authenticated-orcid":true,"given":"Huanmei","family":"Wu","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0746-1809","authenticated-orcid":true,"given":"Lang","family":"Li","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6336-5416","authenticated-orcid":true,"given":"Lijun","family":"Cheng","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2022,8,19]]},"reference":[{"issue":"17\u201318","key":"pcbi.1009421.ref001","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.drudis.2012.05.010","article-title":"Nanotechnology-based combinational drug delivery: an emerging approach for cancer therapy","volume":"17","author":"P Parhi","year":"2012","journal-title":"Drug discovery today"},{"issue":"7","key":"pcbi.1009421.ref002","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/nbt.2284","article-title":"Combinatorial drug therapy for cancer in the post-genomic era","volume":"30","author":"B Al-Lazikani","year":"2012","journal-title":"Nature biotechnology"},{"issue":"7","key":"pcbi.1009421.ref003","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1001\/jama.296.7.827","article-title":"Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society\u2013USA panel","volume":"296","author":"SM Hammer","year":"2006","journal-title":"Jama"},{"issue":"1","key":"pcbi.1009421.ref004","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1586\/14737175.2015.995168","article-title":"Charting a path toward combination therapy for Alzheimer\u2019s disease","volume":"15","author":"D Stephenson","year":"2015","journal-title":"Expert review of neurotherapeutics"},{"issue":"6","key":"pcbi.1009421.ref005","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nmeth.4225","article-title":"Combinatorial CRISPR\u2013Cas9 screens for de novo mapping of genetic interactions","volume":"14","author":"JP Shen","year":"2017","journal-title":"Nature methods"},{"issue":"5","key":"pcbi.1009421.ref006","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nbt.3834","article-title":"Synergistic drug combinations for cancer identified in a CRISPR screen for pairwise genetic interactions","volume":"35","author":"K Han","year":"2017","journal-title":"Nature biotechnology"},{"issue":"1","key":"pcbi.1009421.ref007","first-page":"1","article-title":"Optimal control nodes in disease-perturbed networks as targets for combination therapy","volume":"10","author":"Y Hu","year":"2019","journal-title":"Nature communications"},{"issue":"8","key":"pcbi.1009421.ref008","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/ng.3593","article-title":"Functional characterization of somatic mutations in cancer using network-based inference of protein activity","volume":"48","author":"MJ Alvarez","year":"2016","journal-title":"Nature genetics"},{"key":"pcbi.1009421.ref009","article-title":"ARACNE: an algorithm for the reconstruction of gene regulatory networks in a mammalian cellular context","author":"AA Margolin","year":"2006","journal-title":"BioMed Central"},{"issue":"1","key":"pcbi.1009421.ref010","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/nar\/30.1.207","article-title":"Gene Expression Omnibus: NCBI gene expression and hybridization array data repository","volume":"30","author":"R Edgar","year":"2002","journal-title":"Nucleic acids research"},{"issue":"D1","key":"pcbi.1009421.ref011","doi-asserted-by":"crossref","first-page":"D991","DOI":"10.1093\/nar\/gks1193","article-title":"NCBI GEO: archive for functional genomics data sets\u2014update","volume":"41","author":"T Barrett","year":"2012","journal-title":"Nucleic acids research"},{"issue":"1a","key":"pcbi.1009421.ref012","first-page":"A68","article-title":"The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge","volume":"19","author":"K Tomczak","year":"2015","journal-title":"Contemporary oncology (Poznan, Poland)"},{"issue":"3","key":"pcbi.1009421.ref013","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.cell.2017.06.010","article-title":"Defining a cancer dependency map","volume":"170","author":"A Tsherniak","year":"2017","journal-title":"Cell"},{"issue":"8","key":"pcbi.1009421.ref014","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1158\/2159-8290.CD-16-0154","article-title":"Genomic Copy Number Dictates a Gene-Independent Cell Response to CRISPR\/Cas9 Targeting","volume":"6","author":"AJ Aguirre","year":"2016","journal-title":"Cancer Discovery"},{"issue":"1","key":"pcbi.1009421.ref015","first-page":"1","article-title":"Parallel genome-scale loss of function screens in 216 cancer cell lines for the identification of context-specific genetic dependencies","volume":"1","author":"GS Cowley","year":"2014","journal-title":"Scientific data"},{"issue":"D1","key":"pcbi.1009421.ref016","doi-asserted-by":"crossref","first-page":"D362","DOI":"10.1093\/nar\/gkw937","article-title":"The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible","volume":"45","author":"D Szklarczyk","year":"2017","journal-title":"Nucleic Acids Research"},{"issue":"D1","key":"pcbi.1009421.ref017","doi-asserted-by":"crossref","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","article-title":"DrugBank 5.0: a major update to the DrugBank database for 2018","volume":"46","author":"DS Wishart","year":"2018","journal-title":"Nucleic acids Research"},{"issue":"D1","key":"pcbi.1009421.ref018","doi-asserted-by":"crossref","first-page":"D1011","DOI":"10.1093\/nar\/gkv1108","article-title":"SynLethDB: synthetic lethality database toward discovery of selective and sensitive anticancer drug targets","volume":"44","author":"J Guo","year":"2016","journal-title":"Nucleic acids research"},{"issue":"W1","key":"pcbi.1009421.ref019","doi-asserted-by":"crossref","first-page":"W43","DOI":"10.1093\/nar\/gkz337","article-title":"DrugComb: an integrative cancer drug combination data portal","volume":"47","author":"B Zagidullin","year":"2019","journal-title":"Nucleic acids research"},{"issue":"7","key":"pcbi.1009421.ref020","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1057\/palgrave.jors.2600798","article-title":"Encyclopedia of operations research and management science","volume":"48","author":"SI Gass","year":"1997","journal-title":"Journal of the Operational Research Society"},{"key":"pcbi.1009421.ref021","article-title":"Markov random fields and their applications","author":"R. Kindermann","year":"1980","journal-title":"American mathematical society"},{"key":"pcbi.1009421.ref022","volume-title":"The Oxford dictionary of statistical terms","author":"Y Dodge","year":"2006"},{"key":"pcbi.1009421.ref023","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.spasta.2013.06.004","article-title":"Scaling intrinsic Gaussian Markov random field priors in spatial modelling","volume":"8","author":"SH S\u00f8rbye","year":"2014","journal-title":"Spatial Statistics"},{"issue":"10","key":"pcbi.1009421.ref024","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1016\/j.jspi.2006.07.016","article-title":"Approximate Bayesian inference for hierarchical Gaussian Markov random field models","volume":"137","author":"H Rue","year":"2007","journal-title":"Journal of statistical planning and inference"},{"issue":"13","key":"pcbi.1009421.ref025","doi-asserted-by":"crossref","first-page":"7977","DOI":"10.1073\/pnas.1337088100","article-title":"Systematic discovery of multicomponent therapeutics","volume":"100","author":"AA Borisy","year":"2003","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"6","key":"pcbi.1009421.ref026","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1158\/1535-7163.MCT-15-0843","article-title":"An unbiased oncology compound screen to identify novel combination strategies","volume":"15","author":"J O\u2019Neil","year":"2016","journal-title":"Molecular cancer therapeutics"},{"key":"pcbi.1009421.ref027","author":"CA Stewart","year":"2017","journal-title":"Indiana university pervasive technology institute"},{"issue":"W1","key":"pcbi.1009421.ref028","doi-asserted-by":"crossref","first-page":"W98","DOI":"10.1093\/nar\/gkx247","article-title":"GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses","volume":"45","author":"Z Tang","year":"2017","journal-title":"Nucleic acids research"},{"issue":"3","key":"pcbi.1009421.ref029","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.bbrc.2016.02.023","article-title":"Transferrin receptor regulates pancreatic cancer growth by modulating mitochondrial respiration and ROS generation","volume":"471","author":"SM Jeong","year":"2016","journal-title":"Biochemical and biophysical research communications"},{"issue":"3","key":"pcbi.1009421.ref030","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/cdd.2015.158","article-title":"Ferroptosis: process and function","volume":"23","author":"Y Xie","year":"2016","journal-title":"Cell Death & Differentiation"},{"issue":"10","key":"pcbi.1009421.ref031","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/nrc1951","article-title":"The NCI60 human tumour cell line anticancer drug screen","volume":"6","author":"RH Shoemaker","year":"2006","journal-title":"Nature Reviews Cancer"},{"issue":"7391","key":"pcbi.1009421.ref032","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nature11003","article-title":"The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity","volume":"483","author":"J Barretina","year":"2012","journal-title":"Nature"},{"issue":"5","key":"pcbi.1009421.ref033","first-page":"1","article-title":"SCNrank: spectral clustering for network-based ranking to reveal potential drug targets and its application in pancreatic ductal adenocarcinoma","volume":"13","author":"E Liu","year":"2020","journal-title":"BMC Medical Genomics"}],"updated-by":[{"DOI":"10.1371\/journal.pcbi.1009421","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2022,10,18]],"date-time":"2022-10-18T00:00:00Z","timestamp":1666051200000}}],"container-title":["PLOS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1009421","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,18]],"date-time":"2022-10-18T14:00:01Z","timestamp":1666101601000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1009421"}},"subtitle":[],"editor":[{"given":"James","family":"Gallo","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2022,8,19]]},"references-count":33,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2022,8,19]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1009421","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.09.06.459081","asserted-by":"object"}]},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,19]]}}}